Thursday, 30 June 2016
Stanford, Intermountain start consortium to use genomic data to better match patients to clinical trials
Stanford Cancer Institute, Intermountain Healthcare, Providence Health & Services and Syapse have joined forces to create a consortium to advance cancer care via data sharing and increase access to clinical trials.
Dubbed the Oncology Precision Network (OPN), the consortium will share aggregated cancer genomic data through an advanced software platform in order to bring promising treatment insights to patients and physicians.
"The highest quality cancer care is predicated on clinical trial participation and currently very few cancer patients can access trials that are matched based on the genetic make-up of their cancer," said Dr. Thomas Brown, executive director of the Swedish Cancer Institute and co-chair Providence Health & Services Personalized Medicine Program. "This partnership will further our efforts to provide customized therapies that are based on the biological features of both the patient and their unique cancer."